You are here

PNH

AstraZeneca Gets FDA Approval in Boost to Rare Disease Franchise

BioSpace

Mon, 04/1/24 - 11:58 am

Roche gets first world okay for PNH drug crovalimab

Pharmaphorum

Thu, 02/8/24 - 10:58 am

AZ bags first approval for PNH therapy danicopan, in Japan

Pharmaphorum

Fri, 01/19/24 - 09:38 am

ASH: As Novartis enters PNH market, AstraZeneca shows longer term effect of its latest contender

Fierce Biotech

Mon, 12/11/23 - 10:07 am

Novartis receives FDA approval for Fabhalta to treat PNH in adults

Pharmaceutical Business Review

Wed, 12/6/23 - 10:25 am

paroxysmal nocturnal hemoglobinuria

EHA 2023 – Astrazeneca keeps up its complement defense

EP Vantage

Fri, 06/9/23 - 10:01 am

Novartis’s iptacopan meets primary endpoint in Phase III PNH trial

Clinical Trials Arena

Thu, 04/27/23 - 10:30 am

clinical trials

Roche races to regulators after matching AstraZeneca's rare disease blockbuster in phase 3

Fierce Biotech

Tue, 02/7/23 - 11:04 am

Could This Be Novartis' Next Blockbuster Medicine?

Motley Fool

Fri, 01/27/23 - 10:27 am

AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in

Fierce Biotech

Fri, 12/16/22 - 10:47 am

ASH: Roche records phase 3 rare disease win ahead of Soliris showdown

Fierce Biotech

Mon, 12/12/22 - 10:29 am

Novartis’ oral drug iptacopan tops injectables in head-to-head PNH trial

Pharmaphorum

Mon, 10/24/22 - 10:47 am

clinical trials

BioCryst halts enrollment in all studies for its lead pipeline candidate — shares crash

Endpoints

Fri, 04/8/22 - 10:47 am

clinical trials

EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH

Pharmaforum

Sat, 06/12/21 - 10:26 pm

clinical trials

Apellis set to take on Alexion as FDA clears PNH drug Empaveli

Pharmaforum

Mon, 05/17/21 - 10:39 am

Apellis Pharmaceuticals

Apellis takes the complement fight to Astrazeneca

EP Vantage

Fri, 01/22/21 - 10:30 am

Apellis' Soliris rival gets a date at the FDA for a rare blood disorder, with potentially $400M worth of implications

Endpoints

Mon, 11/16/20 - 10:39 pm

Novartis targets Alexion's fiefdom after showing PNH patients can safely switch from Soliris

Fierce Biotech

Mon, 08/31/20 - 08:54 pm

clinical trials

Alexion Soliris

As CEO bounces back from Covid-19, Apellis says FDA meeting clears path to file for an OK on Soliris rival

Endpoints

Thu, 05/21/20 - 10:31 am

Apellis' blood disorder drug outdoes Alexion's Soliris in improving hemoglobin levels

Reuters

Tue, 01/7/20 - 10:55 am

Apellis Pharmaceuticals

Alexion Pharmaceuticals

Pages